SynthesisFrontiers in pediatrics2026
Balanced crystalloids vs. 0.9% saline in pediatric diabetic ketoacidosis: a systematic review and meta-analysis of randomized controlled trials.
Synthesis in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Fluid resuscitation is a cornerstone in the management of pediatric diabetic ketoacidosis (DKA). While 0.9% normal saline (NS) remains the conventional first-line fluid, concerns regarding its high chloride content and potential to induce hyperchloremic metabolic acidosis have led to increasing interest in balanced crystalloids. However, evidence comparing both strategies in pediatric populations remains limited and inconsistent. Methods: Five databases were searched from inception to 27 April 2026. The primary outcomes were time to resolution of DKA and incidence of new-onset acute kidney injury (AKI). Secondary outcomes included hospital and PICU length of stay, electrolyte disturbances, and major complications. Random-effects models were used. Risk of bias was assessed using the Cochrane RoB 2 tool, and certainty of evidence was evaluated using GRADE. Results: Five RCTs involving 320 patients were included. A modest but statistically significant decrease in the time to DKA resolution (MD: -1.60 h, 95% CI: -3.07 to -0.13) was associated with balanced crystalloids. Current evidence is insufficient to determine the effect of fluid choice on new-onset AKI due to substantial statistical uncertainty (RR: 0.55, 95% CI: 0.17-1.82; Conclusion: Modest benefits in biochemical outcomes were associated with balanced crystalloids. However, due to the small evidence base and low certainty of evidence, it remains unclear if these advantages translate into improvements in clinically important outcomes, particularly rare complications such as cerebral edema and need for mechanical ventilation or inotropic support. Current evidence remains insufficient to support a transition from NS to balanced crystalloids as the initial fluid in pediatric DKA. Further large, multicenter RCTs are needed to better determine the clinical role of balanced crystalloids in this setting. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420261387598, identifier CRD420261387598.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.